Labeler
AstraZeneca Pharmaceuticals LP NDC Codes
AstraZeneca Pharmaceuticals LP lists 83 finished drug products in the FDA NDC Directory under NDC labeler codes 0186, 0310.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Nexium, Seroquel, Xigduo XR, Koselugo, Crestor, Lynparza, Tagrisso, Seroquel XR, Fasenra, Calquence, Pulmicort Respules, Baxfendy, Wainua, Breztri, Saphnelo
- Active ingredients
- Budesonide, Quetiapine fumarate, Dapagliflozin propanediol, Esomeprazole magnesium trihydrate, Formoterol fumarate, Metformin hydrochloride, Selumetinib, Rosuvastatin calcium, Olaparib, Osimertinib, Glycopyrrolate, Benralizumab
- NDC labeler codes
- 0186, 0310
- Strengths
- Budesonide 160 ug/1; Formoterol fumarate 4.5 ug/1; Budesonide 80 ug/1; Acalabrutinib 100 mg/1; Metformin hydrochloride 1000 mg/1; Dapagliflozin propanediol 5 mg/1; Dapagliflozin propanediol 10 mg/1; Eplontersen 45 mg/.8mL; Formoterol 4.8 ug/1; Glycopyrrolate 9 ug/1; Benralizumab 30 mg/mL; Olaparib 100 mg/1; Olaparib 150 mg/1; Osimertinib 40 mg/1; Osimertinib 80 mg/1; Pramlintide acetate 1000 ug/mL; Exenatide 250 ug/mL; Metformin hydrochloride 500 mg/1; Quetiapine fumarate 200 mg/1; Quetiapine fumarate 300 mg/1
- Dosage forms
- Tablet, Film coated, Injection, Solution, Injection, Tablet, Film coated, Extended release, Granule, Delayed release, Aerosol, Metered, Aerosol, Tablet, Tablet, Extended release, Suspension, Granule, Capsule, Powder, For suspension, Capsule, Delayed release, Injection, Powder, Lyophilized, For solution, Capsule, Gelatin coated, Tablet, Coated
- Routes
- Oral, Respiratory (Inhalation), Subcutaneous, Intravenous, Intramuscular
- Drug classes (FDA established)
- Kinase Inhibitor, Corticosteroid, Atypical Antipsychotic, beta2-Adrenergic Agonist, Sodium-Glucose Cotransporter 2 Inhibitor, Proton Pump Inhibitor, Biguanide, HMG-CoA Reductase Inhibitor, Poly(ADP-Ribose) Polymerase Inhibitor, Anticholinergic, Cholinergic Muscarinic Antagonist, Interleukin-5 Receptor alpha-directed Cytolytic Antibody, Antisense Oligonucleotide, Transthyretin-directed RNA Interaction, Type I Interferon Receptor Antagonist, CTLA-4-directed Blocking Antibody, Programmed Death Ligand-1 Blocker, P2Y12 Platelet Inhibitor, Phosphodiesterase 4 Inhibitor, Amylin Analog, GLP-1 Receptor Agonist, Estrogen Receptor Antagonist
- HCPCS / J-code
- J9173 — Injection, durvalumab, 10 mg
- Package NDCs
- 127
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Byettaexenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | 0310-6524 | 00310-6524-01 | — |
| Byettaexenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | 0310-6512 | 00310-6512-01 | — |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 2.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 0310-6225 | 00310-6225-60 | — |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | 0310-6250 | 00310-6250-30 | — |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 0310-6260 | 00310-6260-6000310-6260-95 | — |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 10 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | 0310-6270 | 00310-6270-30 | — |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 10 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 0310-6280 | 00310-6280-3000310-6280-95 | — |
| Nexiumesomeprazole magnesium | Esomeprazole magnesium trihydrate 2.5 mg/1 | Granule, Delayed releaseOral | 0186-4025 | 00186-4025-01 | — |
| Nexiumesomeprazole magnesium | Esomeprazole magnesium trihydrate 5 mg/1 | Granule, Delayed releaseOral | 0186-4050 | 00186-4050-01 | — |
| Brilintaticagrelor | Ticagrelor 90 mg/1 | TabletOral | 0186-0777 | 00186-0777-3900186-0777-60 | — |
| Faslodexfulvestrant | Fulvestrant 50 mg/mL | InjectionIntramuscular | 0310-0720 | 00310-0720-10 | — |
| Seroquel XRquetiapine | Quetiapine fumarate 150 mg/1 | Tablet, Extended releaseOral | 0310-0281 | 00310-0281-60 | — |
| Nexiumesomeprazole magnesium | Esomeprazole magnesium trihydrate 10 mg/1 | Granule, Delayed releaseOral | 0186-4010 | 00186-4010-01 | — |
| Farxigadapagliflozin | Dapagliflozin propanediol 5 mg/1 | Tablet, Film coatedOral | 0310-6205 | 00310-6205-3000310-6205-9000310-6205-95 | — |
| Farxigadapagliflozin | Dapagliflozin propanediol 10 mg/1 | Tablet, Film coatedOral | 0310-6210 | 00310-6210-3000310-6210-3900310-6210-90+1 more | — |
| Pulmicort Respulesbudesonide | Budesonide 1 mg/2mL | SuspensionRespiratory (Inhalation) | 0186-1990 | 00186-1990-04 | — |
| Seroquel XRquetiapine | Quetiapine fumarate 200 mg/1 | Tablet, Extended releaseOral | 0310-0282 | 00310-0282-60 | — |
| Seroquel XRquetiapine | Quetiapine fumarate 300 mg/1 | Tablet, Extended releaseOral | 0310-0283 | 00310-0283-60 | — |
| Seroquel XRquetiapine | Quetiapine fumarate 400 mg/1 | Tablet, Extended releaseOral | 0310-0284 | 00310-0284-60 | — |
| Symbicortbudesonide and formoterol fumarate dihydrate | Budesonide 160 ug/1; Formoterol fumarate 4.5 ug/1 | AerosolRespiratory (Inhalation) | 0186-0370 | 00186-0370-2000186-0370-28 | — |
| Symbicortbudesonide and formoterol fumarate dihydrate | Budesonide 80 ug/1; Formoterol fumarate 4.5 ug/1 | AerosolRespiratory (Inhalation) | 0186-0372 | 00186-0372-2000186-0372-28 | — |
| Nexiumesomeprazole magnesium | Esomeprazole magnesium trihydrate 40 mg/1 | Granule, Delayed releaseOral | 0186-4040 | 00186-4040-01 | — |
| Nexiumesomeprazole magnesium | Esomeprazole magnesium trihydrate 20 mg/1 | Granule, Delayed releaseOral | 0186-4020 | 00186-4020-01 | — |
| Seroquelquetiapine | Quetiapine fumarate 50 mg/1 | Tablet, Film coatedOral | 0310-0278 | 00310-0278-10 | — |
| Seroquelquetiapine | Quetiapine fumarate 400 mg/1 | Tablet, Film coatedOral | 0310-0279 | 00310-0279-10 | — |
| Nexiumesomeprazole magnesium | Esomeprazole magnesium trihydrate 20 mg/1 | Capsule, Delayed releaseOral | 0186-5020 | 00186-5020-3100186-5020-54 | — |
| Nexiumesomeprazole magnesium | Esomeprazole magnesium trihydrate 40 mg/1 | Capsule, Delayed releaseOral | 0186-5040 | 00186-5040-3100186-5040-54 | — |
| Seroquelquetiapine | Quetiapine fumarate 300 mg/1 | Tablet, Film coatedOral | 0310-0274 | 00310-0274-60 | — |
| Pulmicort Respulesbudesonide | Budesonide .25 mg/2mL | SuspensionRespiratory (Inhalation) | 0186-1988 | 00186-1988-04 | — |
| Pulmicort Respulesbudesonide | Budesonide .5 mg/2mL | SuspensionRespiratory (Inhalation) | 0186-1989 | 00186-1989-04 | — |
| Seroquelquetiapine | Quetiapine fumarate 100 mg/1 | Tablet, Film coatedOral | 0310-0271 | 00310-0271-10 | — |
| Seroquelquetiapine | Quetiapine fumarate 200 mg/1 | Tablet, Film coatedOral | 0310-0272 | 00310-0272-10 | — |
| Seroquelquetiapine | Quetiapine fumarate 25 mg/1 | Tablet, Film coatedOral | 0310-0275 | 00310-0275-10 | — |
AstraZeneca Pharmaceuticals LP: common questions
- What is AstraZeneca Pharmaceuticals LP's NDC labeler code?
- 0186, 0310. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for AstraZeneca Pharmaceuticals LP?
- Med-Code's HCPCS directory matches J9173 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.